These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12516983)

  • 21. Cost-effectiveness analysis for health communication programs.
    Guilkey DK; Hutchinson P; Lance P
    J Health Commun; 2006; 11 Suppl 2():47-67. PubMed ID: 17148099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health research: measuring the social, health and economic benefits.
    Frank C; Nason E
    CMAJ; 2009 Mar; 180(5):528-34. PubMed ID: 19164482
    [No Abstract]   [Full Text] [Related]  

  • 23. Bayesian estimation of cost-effectiveness ratios from clinical trials.
    Heitjan DF; Moskowitz AJ; Whang W
    Health Econ; 1999 May; 8(3):191-201. PubMed ID: 10348414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fieller's method and net health benefits.
    Heitjan DF
    Health Econ; 2000 Jun; 9(4):327-35. PubMed ID: 10862076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential inconsistencies between cost-effectiveness and cost-utility analyses. An upstairs/downstairs socioeconomic distinction.
    Rittenhouse BE
    Int J Technol Assess Health Care; 1995; 11(2):365-76. PubMed ID: 7790177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
    Hoerger TJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the special supplement issue.
    McClellan MB; Newhouse JP
    Health Serv Res; 2000 Dec; 35(5 Pt 2):1061-9. PubMed ID: 11130810
    [No Abstract]   [Full Text] [Related]  

  • 29. Advancing the science of health care costing.
    Lipscomb J; Barnett PG; Brown ML; Lawrence W; Yabroff KR
    Med Care; 2009 Jul; 47(7 Suppl 1):S120-6. PubMed ID: 19536003
    [No Abstract]   [Full Text] [Related]  

  • 30. A note on confidence intervals in cost-effectiveness analysis.
    Tambour M; Zethraeus N; Johannesson M
    Int J Technol Assess Health Care; 1998; 14(3):467-71. PubMed ID: 9780533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of health care costs and their statistical analysis for economic evaluation.
    Briggs A; Gray A
    J Health Serv Res Policy; 1998 Oct; 3(4):233-45. PubMed ID: 10187204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost analysis with censored data.
    Huang Y
    Med Care; 2009 Jul; 47(7 Suppl 1):S115-9. PubMed ID: 19536024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 34. Confidence intervals for cost-effectiveness ratios: the use of 'bootstrapping'.
    Campbell M; Torgerson D
    J Health Serv Res Policy; 1997 Oct; 2(4):253-5. PubMed ID: 10182254
    [No Abstract]   [Full Text] [Related]  

  • 35. A framework for cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW
    Health Econ; 2001 Jun; 10(4):303-15. PubMed ID: 11400253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constant and decreasing timing aversion for saving lives.
    Cairns J; van der Pol M
    Soc Sci Med; 1997 Dec; 45(11):1653-9. PubMed ID: 9428085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saving future lives. A comparison of three discounting models.
    Cairns JA; van der Pol MM
    Health Econ; 1997; 6(4):341-50. PubMed ID: 9285228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EFPF (economic frontier production function): DEA (data envelopment analysis) preview.
    Rosenberg D
    J Health Hum Resour Adm; 1991; 14(1):77-83. PubMed ID: 10115640
    [No Abstract]   [Full Text] [Related]  

  • 39. A Bayesian approach to sensitivity analysis.
    Felli JC; Hazen GB
    Health Econ; 1999 May; 8(3):263-8. PubMed ID: 10348421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the (near) equivalence of cost-effectiveness and cost-benefit analyses.
    Phelps CE; Mushlin AI
    Int J Technol Assess Health Care; 1991; 7(1):12-21. PubMed ID: 1903360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.